CHGCY vs MITSY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CHGCY · Chugai Pharmaceutical (ADR)$21.58 ▼ 3.01%
MITSY · Mitsui (ADR)$600.03 ▼ 2.83%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CHGCY -9.1%
- MITSY +13.8%
Head to head
| Metric | CHGCY | MITSY |
|---|---|---|
| Price | $21.58 | $600.03 |
| Change today | ▼ 3.01% | ▼ 2.83% |
| Market cap | $62.80B | $89.54B |
| Return, 3 months | -2.9% | -2.7% |
| Return, year to date | -17.9% | +2.3% |
| Return, 1 year | -10.9% | +13.3% |
| P/E (TTM) | 22.2 | 13.6 |
| P/B | 5.4 | 1.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 3.09% | 2.42% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 56 | 38 |
| 30-day volatility | 34.9% | 25.4% |
| Max drawdown, 1 year | -43.2% | -32.9% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MITSY is the largest of the group by market value.
- MITSY has returned the most over the past year.
- MITSY carries the lowest trailing P/E.
- CHGCY pays the highest dividend yield.
- MITSY has been the calmest stock over the last 30 days.